Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
about
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis.Dropping in on lipid droplets: insights into cellular stress and cancer
P2860
Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@ast
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@en
type
label
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@ast
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@en
prefLabel
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@ast
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@en
P2093
P2860
P50
P356
P1476
Inhibition of hepatic lipogene ...... e and promoting cell survival.
@en
P2093
Carolin Lackner
David S Breen
Ellen M Olzomer
Gregory J Cooney
Jenny D Y Chow
Jill K Slack-Davis
Lindsay E Wu
Marin E Nelson
Stefan R Hargett
Stephen H Caldwell
P2860
P2888
P356
10.1038/NCOMMS14689
P407
P577
2017-03-14T00:00:00Z
P6179
1084128917